gadoteric acid guerbet 0,5 mmol/ml inj. sol. i.v. pre-filled syr.
guerbet - gadoteric acid 27,932 g/100 ml - solution for injection in pre-filled syringe - 0,5 mmol/ml - gadoteric acid 279.32 mg/ml - gadoteric acid
gadoteric acid guerbet 0,5 mmol/ml inj. sol. i.v. pre-filled syr.
guerbet - gadoteric acid 27,932 g/100 ml - solution for injection in pre-filled syringe - 0,5 mmol/ml - gadoteric acid 279.32 mg/ml - gadoteric acid
gadoteric acid guerbet 0,5 mmol/ml inj. sol. i.v. pre-filled syr.
guerbet - gadoteric acid 27,932 g/100 ml - solution for injection in pre-filled syringe - 0,5 mmol/ml - gadoteric acid 279.32 mg/ml - gadoteric acid
gadoteric acid guerbet 0,5 mmol/ml inj. sol. i.v. vial
guerbet - gadoteric acid 27,932 g/100 ml - solution for injection - 0,5 mmol/ml - gadoteric acid 279.32 mg/ml - gadoteric acid
gadoteric acid guerbet 0,5 mmol/ml inj. sol. i.v. vial
guerbet - gadoteric acid 27,932 g/100 ml - solution for injection - 0,5 mmol/ml - gadoteric acid 279.32 mg/ml - gadoteric acid
gadoteric acid guerbet 0,5 mmol/ml inj. sol. i.v. vial
guerbet - gadoteric acid 27,932 g/100 ml - solution for injection - 0,5 mmol/ml - gadoteric acid 279.32 mg/ml - gadoteric acid
gadoteric acid guerbet 0,5 mmol/ml inj. sol. i.v. vial
guerbet - gadoteric acid 27,932 g/100 ml - solution for injection - 0,5 mmol/ml - gadoteric acid 279.32 mg/ml - gadoteric acid
gadoteric acid guerbet 0,5 mmol/ml inj. sol. i.v. vial
guerbet - gadoteric acid 27,932 g/100 ml - solution for injection - 0,5 mmol/ml - gadoteric acid 279.32 mg/ml - gadoteric acid
gadoteric acid guerbet 0,5 mmol/ml inj. sol. i.v. vial
guerbet - gadoteric acid 27,932 g/100 ml - solution for injection - 0,5 mmol/ml - gadoteric acid 279.32 mg/ml - gadoteric acid
dotarem gadoteric acid 279.32mg/ml injection 20 ml pre-filled syringe
guerbet australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - injection, solution - excipient ingredients: meglumine; water for injections - dotarem is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).